Skip to main content

Market Overview

US Stock Futures Up Ahead Of Jobless Claims, Factory Orders Data

US Stock Futures Up Ahead Of Jobless Claims, Factory Orders Data

Pre-open movers

US stock futures traded higher in early pre-market trade. Data on weekly jobless claims and nonfarm business productivity for the fourth quarter will be released at 8:30 a.m. ET. Data on factory orders for January will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average surged 24 points to 18,110.00, while the Standard & Poor's 500 index futures rose 2.70 points to 2,099.20. Futures for the Nasdaq 100 index climbed 7.75 points to 4,452.00.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.54%, STOXX Europe 600 Index surging 0.55% and German DAX 30 index gaining 0.75%. French CAC 40 Index climbed 0.83% and London's FTSE 100 Index rose 0.37%.

In Asian markets, Japan's Nikkei Stock Average rose 0.26%, Hong Kong's Hang Seng Index dropped 1.11%, China's Shanghai Composite Index slipped 0.95% and India's BSE Sensex rose 0.23%.

Broker Recommendation
Analysts at B Riley upgraded American Eagle Outfitters, Inc. (NYSE: AEO) from Neutral to Buy and raised the price target from $15.00 to $20.00.

American Eagle's shares climbed 7.69% to close at $15.96 yesterday.

Breaking news

  • Costco Wholesale Corp. (NASDAQ: COST) reported stronger-than-expected earnings for the fiscal second quarter. To read the full news, click here.
  • Mallinckrodt plc (NYSE: MNK) and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion. To read the full news, click here.
  • Antero Resources Corporation (NYSE: AR) announced today that it has commenced an underwritten public offering of 11,500,000 shares of the Company's common stock. To read the full news, click here.
  • AbbVie (NYSE: ABBV) and Pharmacyclics (NASDAQ: PCYC) today announced a definitive agreement under which AbbVie will acquire Pharmacyclics, and its flagship asset Imbruvica® (ibrutinib), a highly effective treatment for hematologic malignancies. To read the full news, click here.

Related Articles (COST + AEO)

View Comments and Join the Discussion!

Posted-In: B Riley US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at